A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology; DOE/OSTI
- The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology
- Univ. of Hong Kong (Hong Kong). Li Ka Shing Faculty of Medince. School of Public Health. HKU-Pasteur Research Pole
- The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology; The Scripps Research Inst., La Jolla, CA (United States). The Skaggs Institute for Chemical Biology
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) has now become a pandemic, but there is currently very little understanding of the antigenicity of the virus. We therefore determined the crystal structure of CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient, in complex with the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) protein at 3.1-angstrom resolution. CR3022 targets a highly conserved epitope, distal from the receptor binding site, that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV. Structural modeling further demonstrates that the binding epitope can only be accessed by CR3022 when at least two RBDs on the trimeric S protein are in the “up” conformation and slightly rotated. These results provide molecular insights into antibody recognition of SARS-CoV-2.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Biological and Environmental Research (BER)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1629654
- Alternate ID(s):
- OSTI ID: 1630332
- Journal Information:
- Science, Journal Name: Science Journal Issue: 6491 Vol. 368; ISSN 0036-8075
- Publisher:
- AAASCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
Journal Article
·
Thu Dec 03 19:00:00 EST 2020
· PLoS Pathogens
·
OSTI ID:1777660